RxDoctor Payments Data

James Reynolds, OD

Optometrist · Smithfield, NCNPI 1285639526

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (59.2%), education and entertainment — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Coopervision Inc. at 31.1% of the total.

$4,372in general payments, 2019–2025

Across 52 payments — averaging $84.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coopervision Inc.$1K
  • ABB Con-cise Optical Group LLC$1K
  • Notal Vision, Inc.$855
  • Alcon$314
  • Maculogix, Inc.$174
  • Optos, Inc.$162
  • plus $329 from 8 others
$1,140in research payments, 2019–2025

Across 28 payments — averaging $40.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Notal Vision, Inc.$1K

What the payments were for

  • Consulting fees$2877%
  • Speaking & faculty fees$2506%
  • Food & beverage$2,58859%
  • Education$80018%
  • Gifts$481%
  • Entertainment$3999%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,372 in reported general payments places this provider in the 85th percentile of 1,326 optometrist providers in North Carolina.

See all optometrist providers in North Carolina →

Medicare billing

Part B allowed, 2024
$61,650
Medicare patients
292
Services billed
767

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine35$30,762
LumiganBimatoprost24$8,647
Latanoprost193$2,616
Travoprost19$2,034
Tobramycin-DexamethasoneTobramycin/Dexamethasone23$1,018
Prednisolone Acetate28$829
Brimonidine Tartrate36$667
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat84$662
Timolol Maleate25$385
Doxycycline Monohydrate15$178
ErythromycinErythromycin Base13$146
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha11$117

Paid to pharmacies, not to this prescriber.

Other optometrist in Smithfield

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →